These results establish PGK1-driven metabolic reprogramming via the estradiol-Keap1-Nrf2 axis as a critical pathway in GDM pathogenesis, shed new light on the metabolic regulation of OS in GDM, and provide a novel therapeutic strategy for GDM. Here, NFE2L2 is linked to gestational diabetes.